Technology
Health
Biotechnology
Equillium
$5.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.01 (0.18%) Today
-$0.01 (-0.18%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Equillium and other stocks, options, ETFs, and crypto commission-free!
About EQ
Equillium, Inc. Common Stock, also called Equillium, is a biotechnology company, which engages in the development of products for severe immuno-inflammatory disorders with high unmet medical need. Read More Its product pipeline include EQ001, is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly on March 16, 2017 and is headquartered in La Jolla, CA.
Employees
11
Headquarters
La Jolla, California
Founded
2017
Market Cap
95.74M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
9.98K
High Today
$5.58
Low Today
$5.41
Open Price
$5.50
Volume
15.20K
52 Week High
$19.69
52 Week Low
$5.12
Collections
Technology
Health
Biotechnology
Medical
Steel
Metals
Materials
2018 IPO
Price Paid on Robinhood
17% Lower
Right Now
52 Week Low
$5.12
Average Price Paid
$6.65
52 Week High
$19.69
EQ Earnings
-$0.44
-$0.38
-$0.31
-$0.25
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 12, After Hours